Suchergebnisse - "INTRANASAL administration"
-
1
Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer’s Disease
ISSN: 0724-8741, 1573-904XVeröffentlicht: 26.06.2015Veröffentlicht in Pharmaceutical research (26.06.2015)Volltext
Journal Article -
2
Evaluation of intranasal delivery route of drug administration for brain targeting
ISSN: 0361-9230, 1873-2747, 1873-2747Veröffentlicht: United States Elsevier Inc 01.10.2018Veröffentlicht in Brain research bulletin (01.10.2018)“… [Display omitted] •The two main pathways of intranasal drug absorption are the olfactory and trigeminal routes.•The intranasal drugs can bypass the blood-brain …”
Volltext
Journal Article -
3
Air-liquid interface (ALI) impact on different respiratory cell cultures
ISSN: 0939-6411, 1873-3441, 1873-3441Veröffentlicht: Netherlands Elsevier B.V 01.03.2023Veröffentlicht in European journal of pharmaceutics and biopharmaceutics (01.03.2023)“… [Display omitted] The intranasal route has been receiving greater attention from the scientific community not only for systemic drug delivery but also for the …”
Volltext
Journal Article -
4
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
ISSN: 2352-9407Veröffentlicht: Elsevier Ltd 01.12.2022Veröffentlicht in Applied materials today (01.12.2022)“… •The difficulty in the treatment of several diseases which affect the central nervous system (CNS) is related to the low permeation of therapeutic agents …”
Volltext
Journal Article -
5
Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma
ISSN: 1748-0132, 1878-044XVeröffentlicht: Elsevier Ltd 01.08.2023Veröffentlicht in Nano today (01.08.2023)“… Glioblastoma (GBM) is an aggressive brain cancer with an immunosuppressive tumor microenvironment. Here, a copper-based nanoplatform BSO-CAT@MOF-199 @DDM …”
Volltext
Journal Article -
6
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
ISSN: 0105-4538, 1398-9995, 1398-9995Veröffentlicht: Denmark Blackwell Publishing Ltd 01.05.2020Veröffentlicht in Allergy (Copenhagen) (01.05.2020)“… Background Dupilumab, a fully human monoclonal antibody that binds IL‐4Rα and inhibits signaling of both IL‐4 and IL‐13, has shown efficacy across multiple …”
Volltext
Journal Article -
7
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
ISSN: 1087-0156, 1546-1696, 1546-1696Veröffentlicht: New York Nature Publishing Group US 01.10.2022Veröffentlicht in Nature biotechnology (01.10.2022)“… Therapeutics based on short interfering RNAs (siRNAs) delivered to hepatocytes have been approved, but new delivery solutions are needed to target additional …”
Volltext
Journal Article -
8
Intranasally delivered colostrum-derived small extracellular vesicles mitigate acute neuroinflammation in periventricular leukomalacia
ISSN: 0006-8993, 1872-6240, 1872-6240Veröffentlicht: Netherlands Elsevier B.V 01.01.2026Veröffentlicht in Brain research (01.01.2026)“… [Display omitted] •This article demonstrates that intranasally delivered colostrum-derived sEVs can reach the neonatal brain.•The results suggest that …”
Volltext
Journal Article -
9
Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes
ISSN: 1543-8392, 1543-8392Veröffentlicht: United States 01.06.2020Veröffentlicht in Molecular pharmaceutics (01.06.2020)“… Nucleic acid-based therapeutics, including the use of messenger RNA (mRNA) as a drug molecule, has tremendous potential in the treatment of chronic diseases, …”
Weitere Angaben
Journal Article -
10
Effect of preoperative intranasal dexmedetomidine versus placebo on intraoperative shivering in parturients undergoing cesarean section: a randomized controlled trial
ISSN: 1663-9812, 1663-9812Veröffentlicht: Frontiers Media S.A 25.11.2025Veröffentlicht in Frontiers in pharmacology (25.11.2025)“… BackgroundShivering during cesarean section under epidural anesthesia is common and may negatively affect maternal comfort, surgical conditions, and …”
Volltext
Journal Article -
11
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
ISSN: 0168-3659, 1873-4995, 1873-4995Veröffentlicht: Netherlands Elsevier B.V 10.11.2020Veröffentlicht in Journal of controlled release (10.11.2020)“… The diagnosis and treatment of neurological ailments always remain an utmost challenge for research fraternity due to the presence of BBB. The intranasal route …”
Volltext
Journal Article -
12
Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson’s Disease
ISSN: 1936-0851, 1936-086X, 1936-086XVeröffentlicht: United States American Chemical Society 25.01.2022Veröffentlicht in ACS nano (25.01.2022)“… The treatment of Parkinson’s disease (PD) has been hindered by the complex pathologies and multiple membrane barriers during drug delivery. Although exosomes …”
Volltext
Journal Article -
13
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
ISSN: 1097-4172, 1097-4172Veröffentlicht: United States 14.04.2022Veröffentlicht in Cell (14.04.2022)“… The effectiveness of SARS-CoV-2 vaccines and therapeutic antibodies have been limited by the continuous emergence of viral variants and by the restricted …”
Weitere Angaben
Journal Article -
14
The blood–brain barrier: Structure, regulation and drug delivery
ISSN: 2059-3635, 2095-9907, 2059-3635Veröffentlicht: London Nature Publishing Group UK 25.05.2023Veröffentlicht in Signal transduction and targeted therapy (25.05.2023)“… Blood–brain barrier (BBB) is a natural protective membrane that prevents central nervous system (CNS) from toxins and pathogens in blood. However, the presence …”
Volltext
Journal Article -
15
Alzheimer’s Disease: Treatment Strategies and Their Limitations
ISSN: 1422-0067, 1661-6596, 1422-0067Veröffentlicht: Switzerland MDPI AG 12.11.2022Veröffentlicht in International journal of molecular sciences (12.11.2022)“… Alzheimer’s disease (AD) is the most frequent case of neurodegenerative disease and is becoming a major public health problem all over the world. Many …”
Volltext
Journal Article -
16
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
ISSN: 0168-3659, 1873-4995, 1873-4995Veröffentlicht: Netherlands Elsevier B.V 01.02.2024Veröffentlicht in Journal of controlled release (01.02.2024)“… Despite the increasing global incidence of brain disorders, achieving sufficient delivery towards the central nervous system (CNS) remains a formidable …”
Volltext
Journal Article -
17
Intranasal administration of stem cell-derived exosomes for central nervous system diseases
ISSN: 1673-5374, 1876-7958Veröffentlicht: India Wolters Kluwer - Medknow 01.06.2024Veröffentlicht in Neural regeneration research (01.06.2024)“… Abstract Exosomes, lipid bilayer-enclosed small cellular vesicles, are actively secreted by various cells and play crucial roles in intercellular …”
Volltext
Journal Article -
18
Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer's Disease Therapy
ISSN: 1613-6810, 1613-6829, 1613-6829Veröffentlicht: Weinheim Wiley Subscription Services, Inc 01.07.2022Veröffentlicht in Small (Weinheim an der Bergstrasse, Germany) (01.07.2022)“… Alzheimer's disease (AD), as a progressive and irreversible brain disorder, remains the most universal neurodegenerative disease. No effective therapeutic …”
Volltext
Journal Article -
19
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
ISSN: 1097-4172, 1097-4172Veröffentlicht: United States 01.10.2020Veröffentlicht in Cell (01.10.2020)“… The coronavirus disease 2019 pandemic has made deployment of an effective vaccine a global health priority. We evaluated the protective activity of a …”
Weitere Angaben
Journal Article -
20
Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting
ISSN: 1543-8392, 1543-8392Veröffentlicht: United States 01.03.2021Veröffentlicht in Molecular pharmaceutics (01.03.2021)“… Glioblastoma multiforme (GBM) is a highly lethal and aggressive tumor of the brain that carries a poor prognosis. Temozolomide (TMZ) has been widely used as a …”
Weitere Angaben
Journal Article